September 1, 2021 08:43 AM EDT
Pharma

With drug pric­ing re­form po­ten­tial­ly clos­er than ever, Pub­lic Cit­i­zen pens new let­ter call­ing for change

Josh Sullivan

Af­ter pen­ning a let­ter to Speak­er of the House Nan­cy Pelosi and Sen­ate Ma­jor­i­ty Leader Chuck Schumer in June call­ing for drug pric­ing re­form and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

IGM Bio­sciences’ au­toim­mune piv­ot lasts three months af­ter in­ter­im da­ta dis­ap­point

Shore­line cuts staff as its part­ner­ship with Gilead­'s Kite is now in flux

Ver­sant un­veils Light Horse with $62M and a part­ner­ship with No­var­tis

Aio­los team re­unites with $411M for new biotech with obe­si­ty drugs from Chi­na

Ex­clu­sive: First-of-its-kind in­fant DNA ed­it leads to ap­par­ent cure in dis­ease that set back field 25 years ago

Bay­er says elin­zane­tant quelled hot flash­es in women un­der­go­ing can­cer treat­ment

A service from the Financial Times